Only one study examined changes in inflammatory proteins in adults with MS and depression after a CBT intervention and found reductions in IFN-γ cytokine concentration in those that undertook the CBT depression intervention (Mohr et al., 2001). This evidence concerns the gene IFNG and depressive symptom measurement.